Dermatoloxía
Servizo
![Foto de Dermatoloxía](/img/noimage.png)
![Foto de Hospital Universitario de la Princesa](/img/noimage_org.png)
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (113)
2024
-
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513
-
Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 539-546
-
Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. 331-340
-
Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation
Actas Dermo-Sifiliograficas
-
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)
Journal of the European Academy of Dermatology and Venereology
-
Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022)
Contact Dermatitis, Vol. 90, Núm. 5, pp. 486-494
-
Sodium metabisulfite a current low relevant allergen in Spain
Journal of the European Academy of Dermatology and Venereology
-
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
Actas Dermo-Sifiliograficas
2023
-
Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain
Journal of the European Academy of Dermatology and Venereology
-
Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594
-
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)
Actas Dermo-Sifiliograficas
-
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525
-
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
Dermatology and Therapy, Vol. 13, Núm. 1, pp. 329-345
-
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting
International Journal of Dermatology
-
Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain
Dermatitis, Vol. 34, Núm. 4, pp. 315-322
-
Ruxolitinib and Squamous Cell Carcinoma
Actas Dermo-Sifiliograficas
-
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation
Contact Dermatitis, Vol. 88, Núm. 3, pp. 212-219
-
The DERMACLEAR study: Verification results of a natural language processing system in dermatology
JEADV Clinical Practice, Vol. 2, Núm. 4, pp. 775-785
-
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T479-T487
-
[Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T494-T501